Nutrigenomics Market Size & Growth Forecast 2027–2036, By Segments (Application, Product, End Use, Technique), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Nutrigenomics Market size stood at USD 705.7 million in 2026 and is predicted to grow at a 16.53% CAGR from 2027 to 2036, attaining USD 3.26 billion by 2036. The industry revenue for 2027 is calculated at USD 803.93 million.

• Base Year Value (2026): USD 705.7 million
• CAGR (2027-2036): 16.53%
• Forecast Year Value (2036): USD 3.26 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Nutrigenomics Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 42.61% market share in 2026, supported by a mature genetic testing ecosystem, strong personalized nutrition awareness, and broad access to sequencing and data interpretation services.
  • Asia Pacific is projected to grow at a 19.38% CAGR, fueled by rising personalized health adoption, expanding genetic testing infrastructure, and increasing demand for preventive nutrition-based health management.

• Segment Momentum:

  • Obesity accounted for 40.28% of the nutrigenomics market in 2026, driven by strong demand for personalized nutrition strategies that use gene-diet interactions to improve weight management and dietary adherence.
  • Services are both the largest and fastest-growing product segment because testing, interpretation, and personalized nutrition support are essential for converting nutrigenomic insights into practical, individualized outcomes.

• Market Expansion Drivers:

  • Rising chronic disease burden accelerating demand for gene-diet based preventive healthcare solutions.
  • Growing adoption of next-generation sequencing enabling large-scale genomic nutrition profiling.
  • Expansion of consumer-driven personalized nutrition platforms integrating genetic testing with diet planning.

• Leading Market Participants:

  Major players in the nutrigenomics market include Nutrigenomix Inc. (Canada), Metagenics, Inc. (United States), Xcode Life Sciences Private Limited (India), GX Sciences, LLC (United States), DNAlysis Biotechnology (South Africa), Genova Diagnostics, Inc. (United States), dnalife Group (South Africa), Fagron NV (Belgium), Cura Integrative Medicine (United States), Viome Life Sciences, Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 705.7 million
  • 2027 Estimated Market Size: USD 803.93 million.
  • Projected Market Size: USD 3.26 billion by 2036
  • Growth Forecasts: 16.53% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Obesity (Application) | Services (Product) | Hospitals & Clinics (End Use) | Saliva (Technique)
  • Emerging Opportunity Segment: Cancer Research (Application) | Services (Product) | Hospitals & Clinics (End Use) | Blood (Technique)

Market Growth Drivers and Industry Trends

Rising chronic disease burden accelerating demand for gene-diet based preventive healthcare solutions

The growing prevalence of chronic diseases is strengthening the role of personalized prevention, and the nutrigenomics market is benefiting from greater interest in interventions that connect genetic characteristics with dietary choices. Consumers and healthcare professionals are increasingly seeking approaches that can support individualized management of conditions influenced by nutrition, including metabolic and cardiovascular disorders. Gene-diet insights can help identify differences in how individuals respond to nutrients, enabling more tailored dietary recommendations than conventional one-size-fits-all approaches. This shift toward proactive health management is also encouraging greater attention to nutrition as part of long-term disease-risk reduction, supporting demand for nutrigenomic assessments, personalized dietary guidance, and related preventive healthcare services.

Growing adoption of next-generation sequencing enabling large-scale genomic nutrition profiling

Advances in genomic analysis are making next-generation sequencing more accessible for applications involving nutrition and individual health characteristics. Within the nutrigenomics market, the expanding use of these technologies enables researchers and service providers to examine broader sets of genetic information and identify variations associated with nutrient metabolism, dietary response, and disease susceptibility. Improvements in sequencing efficiency and data interpretation can support more comprehensive genetic nutrition profiles while allowing testing platforms to handle increasingly complex genomic information. As sequencing capabilities become integrated with bioinformatics and personalized health applications, the ability to translate genetic data into nutrition-related insights is encouraging broader use across clinical, research, and consumer-oriented settings.

Expansion of consumer-driven personalized nutrition platforms integrating genetic testing with diet planning

The rise of digital health platforms is making personalized nutrition more accessible by combining genetic testing with individualized dietary recommendations and ongoing lifestyle guidance. This trend is supporting the nutrigenomics market as consumers increasingly use online platforms to obtain insights into how their genetic profiles may relate to food choices, nutrient requirements, and wellness goals. Integration with digital questionnaires, meal-planning tools, mobile applications, and nutrition tracking can make genetic information easier to interpret and apply in everyday routines. The convenience of receiving personalized recommendations through consumer-focused platforms is also broadening engagement beyond traditional clinical settings, while recurring digital services can encourage continued use of genetic nutrition insights.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising chronic disease burden accelerating demand for gene-diet based preventive healthcare solutions	2.10%	High	North America, Europe	High	Near Term
Growing adoption of next-generation sequencing enabling large-scale genomic nutrition profiling	1.80%	Moderate	North America, Asia Pacific	High	Mid Term
Expansion of consumer-driven personalized nutrition platforms integrating genetic testing with diet planning	1.50%	Low	North America, Asia Pacific, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest share of the nutrigenomics market at 42.61% in 2026, supported by advanced genomics research capabilities, growing interest in personalized nutrition, and strong integration of genetic insights into preventive healthcare. The region benefits from well-developed biotechnology and healthcare infrastructure, enabling greater use of genomic testing and data-driven approaches to understand how individual genetic profiles interact with dietary factors. Increasing consumer awareness of personalized wellness, alongside research into nutrition-related chronic conditions, is encouraging demand for nutrigenomic applications. Continued investment in precision health, improved access to genetic testing, and collaboration between healthcare and life sciences stakeholders further strengthen the regional market.

Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, rising awareness of personalized health, and increasing investment in genomics and biotechnology. Growing interest in preventive healthcare and individualized dietary recommendations is creating new opportunities for nutrigenomics applications across both clinical and consumer settings. The region's diverse population and increasing availability of genetic testing are also supporting research into diet, lifestyle, and disease susceptibility. Digital health adoption and expanding capabilities in genomic data analysis are further improving access to personalized nutrition services, while greater healthcare modernization is creating a favorable environment for broader market adoption.

Key Country Insights

United States

Personalized Nutrition Platforms

The U.S. nutrigenomics market is expanding through consumer interest in personalized wellness and genetic testing services. Companies are integrating genomic insights with digital health platforms to provide individualized nutrition recommendations and develop targeted dietary products.

Japan

Healthy Aging Applications

Japan is applying nutrigenomics to support healthy aging and chronic disease management initiatives. The country's focus on preventive health is encouraging development of nutrition programs and functional food products tailored to individual genetic characteristics.

South Korea

Consumer Genomics Services

South Korea is witnessing increasing demand for direct-to-consumer genetic testing linked to nutrition and wellness recommendations. Businesses are developing integrated platforms that combine genomic insights with personalized dietary guidance and digital health monitoring services.

Germany

Clinical Nutrition Research

Germany is emphasizing evidence-based nutrigenomics applications that connect genetic data with preventive healthcare strategies. Research institutions and healthcare providers are exploring genetic profiling tools to support personalized dietary interventions and precision nutrition programs.

France

Preventive Health Integration

France is exploring nutrigenomics as part of broader preventive healthcare and nutrition strategies. The market is characterized by growing interest in scientific validation and personalized nutrition programs that align dietary interventions with genetic predispositions.

Italy

Functional Nutrition Development

Italy's nutrigenomics market is benefiting from interest in personalized dietary approaches and premium nutrition products. Companies and research organizations in Italy are examining how genetic information can support tailored nutrition recommendations and specialized functional food offerings.

Segment Leadership and Growth Trends

 

Application Segment Analysis: Obesity (Largest Segment) vs Cancer Research (Fastest-Growing Segment)

The obesity segment represented the largest share of 40.28% in 2026 in the nutrigenomics market, reflecting growing interest in understanding how genetic variations influence dietary response, metabolism, and susceptibility to weight-related conditions. Nutrigenomic approaches can help researchers examine interactions between nutritional factors and individual biological characteristics, supporting more personalized approaches to obesity management. Rising attention to precision nutrition and the complex biological drivers of obesity is sustaining research activity in this area.

Cancer research is advancing rapidly as researchers increasingly investigate the interaction between nutrition, genetic characteristics, metabolism, and cancer-related biological pathways. Nutrigenomics can provide insights into how dietary factors may influence disease mechanisms and individual responses, supporting research into personalized nutritional strategies alongside broader cancer studies. The expanding focus on precision medicine and individualized disease management is creating greater opportunities for nutrigenomic applications in cancer research.

Product Segment Analysis: Services (Largest & Fastest-Growing Segment)

Services held the largest share and are also the fastest-growing segment of the nutrigenomics market, reflecting the specialized expertise required to interpret genetic, nutritional, and biological information. These services support activities such as genomic analysis, personalized nutrition assessment, research consultation, and data interpretation, allowing healthcare and research organizations to access specialized capabilities without building every function internally. Increasing interest in personalized nutrition, advances in genomic analysis, and the growing complexity of integrating genetic information with dietary recommendations are strengthening demand for service-based offerings.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Application	Obesity, Cardiovascular Diseases, Cancer Research, Others	Obesity	Cancer Research
Product	Reagents & Kits, Services	Services	Services
End Use	Hospitals & Clinics, Others	Hospitals & Clinics	Hospitals & Clinics
Technique	Saliva, Buccal Swab, Blood	Saliva	Blood

Competitive Landscape and Market Positioning

Prominent players in the nutrigenomics market:

1. Nutrigenomix Inc. (Canada)

2. Metagenics Inc. (United States)

3. Xcode Life Sciences Private Limited (India)

4. GX Sciences LLC (United States)

5. DNAlysis Biotechnology (South Africa)

6. Genova Diagnostics Inc. (United States)

7. dnalife Group (South Africa)

8. Fagron NV (Belgium)

9. Cura Integrative Medicine (United States)

10. Viome Life Sciences Inc. (United States)

Growing interest in personalized nutrition is shaping the nutrigenomics market through advanced genetic-based health insights. Continuous research in gene-diet interaction is improving personalization accuracy. Expansion of consumer health platforms is increasing accessibility to tailored nutrition solutions. The nutrigenomics market is evolving through integration of genomics with preventive healthcare models.

Industry Development/News

Company Name	Date	Key Development
ICAR–Indian Institute of Millets Research	Jul-24	The inauguration of an Advanced Nutrigenomics Laboratory at the Global Centre of Excellence on Millets establishes new infrastructure for researching the intersection of genetics and millet-based diets. This facility enhances regional research capacity for personalized nutrition, providing a foundation for future development in functional food science and nutrigenomics applications tailored to specific dietary profiles.
Xcode Life	Jun-23	The introduction of a comprehensive genetic nutrition test in the Indian market marks a significant expansion of commercialized nutrigenomic diagnostics. By assessing approximately 50 genetic factors related to macronutrient metabolism, micronutrient deficiencies, and dietary sensitivities, the offering enables data-driven personalized nutrition strategies, directly impacting the adoption of genomics-based weight management and lifestyle optimization services for consumers.
Dr. Mohan’s Diabetes Specialities Centre	Jul-24	The launch of a Genomic Lifestyle Counselling service integrates advanced genetic insights into clinical diabetes and health management pathways. By leveraging individualized genomic profiles to inform specific nutritional and lifestyle interventions, the center strengthens its preventive healthcare portfolio and demonstrates a strategic shift toward incorporating nutrigenomics into professional, evidence-based patient care protocols.
GX Sciences	Jun-23	The partnership with GetHairMD to deploy specialized oral swab genetic testing reflects an expansion of nutrigenomics into targeted clinical practice. By enabling practitioners to utilize unique genetic profiles for developing personalized treatment plans, this collaboration demonstrates the commercial scalability of genetic diagnostic tools in specialized care environments, enhancing the integration of personalized health solutions into broader medical service offerings.
Nutrillion	Jul-24	The launch of a personalized nutrition mobile application signifies a strategic move to digitize and scale access to nutrigenomics-based wellness solutions. By delivering tailored nutrition recommendations based on individual user profiles, the platform facilitates greater market penetration of personalized nutrition services, bridging the gap between genetic analysis and actionable, consumer-facing digital health interventions.